Olarte, Aiza .
HRN: 17-98-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFUROXIME 1.5GM (VIAL)
04/20/2024
04/27/2024
IV
1.5gram
Q8
S/P Ex Lap, Vaginal Exploration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes